CLVS

Clovis Oncology, Inc.
CLVS

Overview Fund Activity
Delisted

CLVS was delisted on the 20th of December, 2022.

Back to rankings

135 hedge funds and large institutions have $718M invested in Clovis Oncology, Inc. in 2016 Q1 according to their latest regulatory filings, with 21 funds opening new positions, 48 increasing their positions, 42 reducing their positions, and 41 closing their positions.

Holders
135
Holders Change
-22
Holders Change %
-14.01%
% of All Funds
3.6%
Holding in Top 10
5
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-16.67%
% of All Funds
0.13%
New
21
Increased
48
Reduced
42
Closed
41
Calls
$70.5M
Puts
$36.6M
Net Calls
+$33.9M
Net Calls Change
+$14.9M

Top Buyers

1
RG
1
Redmile Group
California
$59.5M
2
Renaissance Technologies
2
Renaissance Technologies
New York
$9.9M
3
HM
3
HealthCor Management
New York
$38.4M
4
Westfield Capital Management
4
Westfield Capital Management
Massachusetts
$6.68M
5
State Street
5
State Street
Massachusetts
$34.5M

Top Sellers

1
Balyasny Asset Management
1
Balyasny Asset Management
Illinois
$0
2
Fidelity Investments
2
Fidelity Investments
Massachusetts
$27.6M
3
Millennium Management
3
Millennium Management
New York
$5.58M
4
Goldman Sachs
4
Goldman Sachs
New York
$19.6M
5
Tudor Investment Corp
5
Tudor Investment Corp
Connecticut
$266K
Name Market Value Shares Shares
Change 		Shares
Change %
PC
1
PointState Capital
New York
$69M 3,596,180 +92,280 +3%
PAI
2
Palo Alto Investors
California
$66.5M 3,461,365 -86,354 -2%
RG
3
Redmile Group
California
$59.5M 3,099,336 +1,303,400 +73%
Vanguard Group
4
Vanguard Group
Pennsylvania
$42.9M 2,234,421 +1,153 +0.1%
HM
5
HealthCor Management
New York
$38.4M 2,000,000 +475,000 +31%
PHS
6
PFM Health Sciences
California
$36M 1,874,384 -204,056 -10%
State Street
7
State Street
Massachusetts
$34.5M 1,797,874 +313,893 +21%
T. Rowe Price Associates
8
T. Rowe Price Associates
Maryland
$30M 1,564,605 -18,290 -1%
Fidelity Investments
9
Fidelity Investments
Massachusetts
$27.6M 1,436,456 -1,290,854 -47%
O
10
OppenheimerFunds
New York
$23.9M 1,246,660 +1,150 +0.1%
BFA
11
BlackRock Fund Advisors
California
$23M 1,198,921 +44,935 +4%
NMC
12
NEA Management Company
Maryland
$21.9M 1,139,890 – –
D.E. Shaw & Co
13
D.E. Shaw & Co
New York
$20.7M 1,078,921 +135,402 +14%
AA
14
Antipodean Advisors
New York
$20.4M 1,059,901 -208,757 -16%
Goldman Sachs
15
Goldman Sachs
New York
$19.6M 1,021,029 -848,103 -45%
BIT
16
BlackRock Institutional Trust
California
$15.8M 825,085 +54,476 +7%
O
17
OrbiMed
New York
$12.7M 660,900 -68,700 -9%
LPU
18
Lansdowne Partners (UK)
United Kingdom
$10.7M 559,534 – –
BB
19
BB Biotech
Switzerland
$10.1M 528,188 – –
Renaissance Technologies
20
Renaissance Technologies
New York
$9.9M 515,400 +515,400 New
VAM
21
Visium Asset Management
New York
$9.6M 500,000 -36,967 -7%
VVM
22
Versant Venture Management
California
$7.82M 407,416 – –
Northern Trust
23
Northern Trust
Illinois
$6.83M 341,336 +9,037 +3%
Westfield Capital Management
24
Westfield Capital Management
Massachusetts
$6.68M 347,660 +347,660 New
Millennium Management
25
Millennium Management
New York
$5.58M 290,411 -883,462 -75%
1
2 3 4 5